StockWatch
·
Pharmaceuticals
Corporate Governance11 Jul 2026, 01:30 pm

Advik Laboratories: Zero Investor Complaints for Q1 FY27

AI Summary

Advik Laboratories Ltd has reported its investor complaint status for the quarter ended June 30, 2026. As per SEBI regulations, the company stated that there were no pending investor complaints at the beginning of the quarter, no new complaints received during the quarter, and consequently, no unresolved complaints at the end of the quarter. This indicates a smooth operational period concerning investor grievances.

Key Highlights

  • No investor complaints pending at the start of the quarter.
  • No new investor complaints were received during the quarter.
  • Zero unresolved investor complaints at the end of the quarter.
  • Filing adheres to SEBI LODR Regulations, 2015.